The global novel drug delivery systems (NDDS) in cancer therapy market is expected to reach USD 26.61 billion by 2025,
according to a new report by Grand View Research, Inc. The market is primarily
driven by global rise in incidence of cancer, increase in research activities
for developing novel drug delivery technologies, and availability of research
funding for ongoing projects.
Many key players in this market are
investing in R&D of novel and advanced products. This can also be
attributed to increase in patent expirations. For instance, the R&D
expenditure of Celgene Corporation increased from USD 3,697.3 million in 2015
to USD 4,470.1 million in 2016. Increase in R&D spending was directed
toward enhancing product pipeline and for regulatory approvals of new products.
In addition, rise in healthcare expenditure
for diagnosis and treatment of cancer and awareness about alternative therapies
are expected to boost market growth. Improvement in healthcare infrastructure
in developing nations and increase in awareness about new treatment methods for
cancer are also anticipated to propel the market during the forecast
period.
North America held the largest market share
in 2016. Local presence of a large number of manufacturers, ongoing regulatory
approvals for new drugs, and availability of research funding for new methods
of treatment for this disorder are key factors that can be attributed to this
region’s dominance in the global market. However, Asia Pacific is expected to
grow at the highest rate during the forecast period. This can be attributed to
rise in initiatives that boost cancer research projects, increase in healthcare
expenditure for cancer therapy, improvement in healthcare infrastructure, large
geriatric population base, and rise in awareness owing to medical conferences
and meetings in the region.
Browse full report by Grand View
Research : https://www.grandviewresearch.com/industry-analysis/novel-drug-delivery-systems-in-cancer-therapy
Further Key Findings From the Report Suggest:
·
The nanoparticles segment held the largest
revenue share in 2016 due to increase in funding for research using these
particles
·
The embolization particles segment is
expected to grow at the highest rate during the forecast period owing to higher
precision rate and accurate drug delivery
·
North America dominated the global market
due to presence of a large number of cancer patients and favorable
reimbursement scenario
·
Some of the key players are Celgene
Corporation; Teva Pharmaceutical Industries, Ltd.; GALEN; Shire; Johnson &
Johnson Services, Inc.; and Spectrum Pharmaceuticals, Inc.
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research, Inc. has segmented the
novel drug delivery systems (NDDS) in cancer therapy market on the basis of
product and region:
Product
Outlook (Revenue, USD Million, 2014 - 2025)
·
Nanoparticles
o Liposomes
o Polymers
o Micelles
o Other nanoparticles
·
Embolization particles
o PVA particles
o Drug eluting beads
o Liquid emboli
o Other embolization particles
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o U.K.
·
Asia Pacific
o China
o Japan
·
Latin America
o Brazil
o Mexico
·
Middle East & Africa
o South Africa
View Press Release of this research report by Grand View
Research: https://www.grandviewresearch.com/press-release/global-novel-drug-delivery-systems-in-cancer-therapy-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
